A systematic review of the literature exploring the interplay between prostate cancer and type two diabetes mellitus

被引:23
作者
Crawley, Danielle [1 ]
Chamberlain, Florence [2 ]
Garmo, Hans [1 ]
Rudman, Sarah [2 ]
Zethelius, Bjorn [3 ,4 ]
Holmberg, Lars [1 ,5 ]
Adolfsson, Jan [6 ]
Stattin, Par [5 ]
Carroll, Paul [7 ]
Van Hemelrijck, Mieke [1 ]
机构
[1] Kings Coll London, Translat Oncol & Urol Res Grp, London SE1 9RT, England
[2] Guys & St Thomas NHS Fdn Trust, Dept Med Oncol, London SE1 9RT, England
[3] Uppsala Univ, Dept Publ Hlth & Geriatr, S-75105 Uppsala, Sweden
[4] Med Prod Agcy, S-75103 Uppsala, Sweden
[5] Uppsala Univ, Dept Surg Sci, S-75105 Uppsala, Sweden
[6] Karolinska Inst, Dept Clin Sci Intervent & Technol, S-17177 Stockholm, Sweden
[7] Guys & St Thomas NHS Fdn Trust, Dept Diabet & Endocrinol, London SE1 9RT, England
关键词
type two diabetes; prostate cancer; review;
D O I
10.3332/ecancer.2018.802
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Prostate cancer (PCa) and type two diabetes mellitus (T2DM) are both increasing prevalent conditions and often occur concurrently. However, the relationship between the two is more complex than just two prevalent conditions co-existing. This review systematically explores the literature around the interplay between the two conditions. It covers the impact of pre-existing T2DM on PCa incidence, grade and stage, as well as exploring the impact of T2DM on PCa outcomes and mortality and the interaction between T2DM and PCa treatments.
引用
收藏
页数:27
相关论文
共 80 条
[1]   Impact of Androgen Deprivation Therapy on Cardiovascular Disease and Diabetes [J].
Alibhai, Shabbir M. H. ;
Duong-Hua, Minh ;
Sutradhar, Rinku ;
Fleshner, Neil E. ;
Warde, Padraig ;
Cheung, Angela M. ;
Paszat, Lawrence F. .
JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (21) :3452-3458
[2]   Cancer among patients with diabetes, obesity and abnormal blood lipids: a population-based register study in Sweden [J].
Attner, Bo ;
Landin-Olsson, Mona ;
Lithman, Thor ;
Noreen, Dennis ;
Olsson, Hakan .
CANCER CAUSES & CONTROL, 2012, 23 (05) :769-777
[3]   Type 2 diabetes and risk of prostate cancer: a meta-analysis of observational studies [J].
Bansal, D. ;
Bhansali, A. ;
Kapil, G. ;
Undela, K. ;
Tiwari, P. .
PROSTATE CANCER AND PROSTATIC DISEASES, 2013, 16 (02) :151-158
[4]   Long-term All-Cause Mortality in Cancer Patients With Preexisting Diabetes Mellitus A Systematic Review and Meta-analysis [J].
Barone, Bethany B. ;
Yeh, Hsin-Chieh ;
Snyder, Claire F. ;
Peairs, Kimberly S. ;
Stein, Kelly B. ;
Derr, Rachel L. ;
Wolff, Antonio C. ;
Brancati, Frederick L. .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2008, 300 (23) :2754-2764
[6]   Type 2 diabetes and the risk of mortality among patients with prostate cancer [J].
Bensimon, Leah ;
Yin, Hui ;
Suissa, Samy ;
Pollak, Michael N. ;
Azoulay, Laurent .
CANCER CAUSES & CONTROL, 2014, 25 (03) :329-338
[7]   Diabetes mellitus and risk of prostate cancer: a meta-analysis [J].
Bonovas, S ;
Filioussi, K ;
Tsantes, A .
DIABETOLOGIA, 2004, 47 (06) :1071-1078
[8]   Quantifying the Evidence for the Risk of Metabolic Syndrome and Its Components following Androgen Deprivation Therapy for Prostate Cancer: A Meta-Analysis [J].
Bosco, Cecilia ;
Crawley, Danielle ;
Adolfsson, Jan ;
Rudman, Sarah ;
Van Hemelrijck, Mieke .
PLOS ONE, 2015, 10 (03)
[9]   Diabetes mellitus is associated with elevated risk of mortality amongst patients with prostate cancer: a meta-analysis of 11 cohort studies [J].
Cai, Hongzhou ;
Xu, Zicheng ;
Xu, Ting ;
Yu, Bin ;
Zou, Qing .
DIABETES-METABOLISM RESEARCH AND REVIEWS, 2015, 31 (04) :336-343
[10]   Association between duration and type of androgen deprivation therapy and risk of diabetes in men with prostate cancer [J].
Crawley, Danielle ;
Garmo, Hans ;
Rudman, Sarah ;
Stattin, Par ;
Haggstrom, Christel ;
Zethelius, Bjorn ;
Holmberg, Lars ;
Adolfsson, Jan ;
Van Hemelrijck, Mieke .
INTERNATIONAL JOURNAL OF CANCER, 2016, 139 (12) :2698-2704